PERK Antibody (N-term Q163) [APR10844G] from Leading Biology | Biocompare.com

Be the first to write a review!

Get Pricing from
Leading Biology for
PERK Antibody (N-term Q163) [APR10844G]

The PERK Antibody (N-term Q163) [APR10844G] from Leading Biology is a Rabbit Polyclonal antibody to EIF2AK3. This antibody recognizes Human antigen. The PERK Antibody (N-term Q163) [APR10844G] has been validated for the following applications: Immunohistochemistry, Immunohistochemistry - fixed, and Western Blot.

Product Specs
ItemPERK Antibody (N-term Q163) [APR10844G]
CompanyLeading Biology
Price Pricing Info Get Pricing Get Quote for this Product
Catalog NumberAPR10844G
Quantity100 µl
ApplicationsWB, IHC-P
Conjugate/TagUnconjugated
HostRabbit
Brand/TrademarkLeading Biology
ClonalityPolyclonal
ReactivityH
FormatPurified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
ImmunogenThis PERK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 148-175 amino acids from the N-terminal region of human PERK
TargetPERK
PurityAffinity Purification
NCBI Full Gene Nameeukaryotic translation initiation factor 2 alpha kinase 3
NCBI Gene AliasesPERK, WRS, PEK
ValidationWB, IHC-P

Add to Compare List

Leading Biology

Leading Biology

2600 Hilltop DR

Building G, B Suite C138

Richmond, CA 94806

United States

Phone: 1-661-524(LBI)-0262

Email: info@leadingbiology.com

Company Profile

Website: leadingbiology.com

Be the First to Write a Review!

The Magic’s In the Membrane: Choose Wisely for Best Western Blot Results
April 08, 2013
It is important to validate the correct membrane type for your experimental conditions. Choosing the correct membrane type for Western blotting can help prevent transfer inefficiencies, reduce background after staining ... read more

Watch Video: The Immobilon^® Family - a Western story
Western blotting is one of the most commonly used techniques in the lab, yet difficulties persist in... Read More